AdvaMed®’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
According to a senior toxicologist in a RealClearPolicy op-ed, the EPA draws unreasonable conclusions about the health risks of the ethylene oxide used to sterilize medical technology.
AdvaMed® convened sustainability leaders at its annual MedTech Conference last fall for a panel discussion that featured panelists across the entire medtech value chain.
AdvaMed® and its member companies are working with the U.S. government on medtech donations for humanitarian aid following the devastating earthquakes in southeast Turkey and northern Syria.
The case involved expansive Biometric Privacy Act (BIPA) liability for medical device manufacturers. The device at issue was a medstation manufactured by BD that stores patient pharmaceuticals that can be…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
It is easy to take for granted the role medtech plays in our everyday lives. From heart valves, imaging equipment, and pacemakers to continuous glucose monitors, we rely on these technologies to…
Chris White, AdvaMed®’s General Counsel, explores the GAO’s recent report as “a welcome independent review raising attention to the need for disclosure and regulation of the litigation financing that fuels…
The Federal Trade Commission published a proposed rule in the Federal Register that would, among other things, prohibit employers from imposing non-compete agreements on their employees.
AdvaMed® was privileged to host a delegation from Korea’s Ministry of Food and Drug Safety (MFDS) at our offices for an informative session on the regulation of digital health technology.
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-316-1423
Heart attack symptoms in women can be different than in men and less well-known as heart attack-related. Women need their heart disease recognized and treated on equal footing with men.
Join over 500 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.